Six non-glucose polyols-mannose, fructose, 1-deoxyglucose, mannitol, glucitol, and inositol-were identified and evaluated in human serum and cerebrospinal fluid by gasliquidchromatography and by gas-liquid chromatography! mass spectrometry. Concentrations of fructose, mannose, and inositol in the serum of healthy persons or children without metabolic diseases varied with age, as already reported for 1-deoxyglucose. Fructose, inositol, and glucitol concentrations in cerebrospinal fluid significantly exceeded those in serum. The method described here for determining polyols and for evaluating polyol patterns in serum, as well as the resulting data on children and healthy subjects, should be useful in investigations of the clinical and physiological significance of polyols.
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Several non-glucose polyois are present in serum and cerebrospinal fluid (CSF),2 and we know something of their clinical significance.
Accumulation of sorbitol within the Schwann cells of diabetics causes cellular edema of neurons, with eventual cell death (1, 2) . Deposition of this compound in the lens of diabetics induces so-called diabetic cataracts (3) .
The concentration of 1-deoxyglucose (1,5-anhydroglucitol) (4-6) is subnormal in serum from untreated diabetics but increases on treatment with insulin; it thus serves as a new metabolic marker of sugars. Investigations in experimental animals suggest that 1-deoxyglucose is utilized more effectively in diabetic patients than in non-diabetics (7) .
The myoinositol content of normal nerve tissue is nearly 100-fold the concentration in plasma, because of an active transport system for this polyol (8) 
GLC and GLC-MS procedures.
In determining the concentration of polyols, we used adomtol as the internal standard, adding 1 g of adonitol to each sample before vaporization.
The mass-chromatogram was recorded by sequential scanning for 4 s. Other procedures for the analysis were already described (6) . The sensitivity was such that 0.5 mg of 1-deoxyglucose per liter or 1 mg of polyols per liter could be determined in 0.1 mL of initial sample of serum or CSF.
Results

Identification of polyols.
The GLC analysis of trimethylsilyl derivatives of polyols in serum and CSF showed the peaks originating from a-mannose, 1-deoxyglucose, J3-mannose, inositol, and the two trimethylsilyl derivatives of fructose ( Figure   1 , A-C). The peaks corresponding to the trimethylsilyl derivatives of mannitol and glucitol were detected in sera from cord blood. Identification of the peaks other than a-mannose was confirmed by the total coincidence between these peaks and those for each polyol standard in terms of their elution times on GLC and their massspectra obtained with GLC-MS (Figure 2, A-F) . Molecular ions were detected in the analysis of trimethylsilyl derivatives of 1-deoxyglucose and inositol. GLC peak 2 was identified as the trimethylsilyl derivative of a-mannose from its retention time, but its mass spectrum showed the fragment ion of mle 473, which was not detected as a trimethylsilyl derivative of known mannose (Figure 2A ).
Mass-chromatography confirmed that peak 2 originated from a-mannose contaminated with a small amount of fructose ( Figure 3, A-D) .
Determination of polyols.
We prepared four solutions, containing 10, 5, 2, and 1 mg of each polyol per liter of 
, and inositol (F) from serum after distilled water, divided these into six aliquots each, and injected them into the GLC as described previously (6). Table 1 summarizes the results. In spite of incomplete resolution of the peaks for fructose and a-mannose, we could determine mannose with satisfactory accuracy. The precision of GLC determination of polyols in relatively high concentration is reported elsewhere (10). Polyols in serum. We examined the above-listed samples for polyols such as mannose, fructose, 1-deoxyglucose, mannitol, glucitol, and inositol. Measurable mannitol and glucitol were detected only in sera from cord blood ( Table 2 ). The variation in polyol content of serum with age was statistically significant by Student's t-test ( Table 2 ). The relation between age and 1-deoxyglucose concentration has been reported elsewhere (11) . Polyols in CSF. We examined the concurrently obtained samples of serum and CSF for polyols. Fructose, inositol, and glucitol concentration in CSF significantly exceeded those in serum (Table 3) , but for 1-deoxyglucose, mannose, and mannitol these differences were not statistically significant (Student's t-test).
Discussion
The presence as well as the clinical and physiological significance of the several polyols in human serum and CSF has already been reported (12) (13) (14) . In these studies, the samples were treated with hexokinase or glucose oxidase and catalase before derivatization, presumably to remove the hexoses that would disturb peak resolution on GLC of polyols. Thus such compounds as fructose and mannose, which are normally present in small but measurable amounts in body fluids, were not measured in those studies. Recently, Monson and Wilkinson (15) reported a method for '4 '7 13 1 is 4 determining mannose in serum; however, they did not mention the resolution of mannose and fructose by GLC (these sugars are usually too poorly resolved for accurate measurement).
In contrast, GLC of the trimethylsilyl derivatives of fructose produces three peaks, only the smallest one of which contaminates (negligibly) the peak originating from a-mannose.
Because we used an all-glass capillary column with high resolving capacity, we could identify and accurately However, he also did not measure mannose and fructose. In our studies, manrntol and sorbitol were not Table 1 . PrecisIon of GLC Determination of detected in serum except in that from cord blood. We
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therefore estimate the concentration of these polyols in Polyol concn, mg/L serum to be 1 mgfL or less, given the sensitivity of our analysis. The inositol concentration in serum reported by
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Servo and Pitkfinen (14) reported that the concentration of myoinositol in CSF was significantly greater than in plasma. We confirmed this and also found that fructose and sorbitol concentrations were higher in CSF than in serum. In contrast, the concentrations of glucose and 1-deoxyglucose in CSF were lower than in serum. These concentration differences between CSF and serum were statistically significant for glucose, but not for 1-deoxyglucose.
The reasons for this are still unknown, but we presume that there may be an active transport of some polyols across the blood-brain 
